Back to Results
First PageMeta Content
HIV/AIDS / Pharmacology / Sculptra / Pharmaceutical Benefits Scheme / Lipoatrophy / Botulinum toxin / Medicare / HIV test / Injection / Medicine / Health / Healthcare in Australia


Medical Services Advisory Committee Public Summary Document
Add to Reading List

Document Date: 2014-08-07 23:58:22


Open Document

File Size: 61,54 KB

Share Result on Facebook

City

Melbourne / /

Company

Australia Pty Ltd / Sanofi / /

Currency

USD / /

Event

FDA Phase / /

IndustryTerm

technology assessment report / medical technologies / health technology assessment work / technology evaluation / /

MedicalCondition

hemi-facial spasm / HIV / spasmodic dysphonia / severe axillary hyperhidrosis / depression / /

MedicalTreatment

antiretroviral therapy / Highly active antiretroviral therapy / HAART / /

Organization

Pharmaceutical Benefits Advisory Committee / National Science Foundation / Medical College / Australian Health Ministers’ Advisory Council / Medical Services Advisory Committee / Medicare / /

Position

Governor / Minister / /

Product

Sculptra® / /

URL

http /

SocialTag